Pier Capital’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-61,028
Closed -$5.95M 137
2015
Q1
$5.95M Buy
61,028
+23,723
+64% +$2.31M 0.9% 78
2014
Q4
$3.46M Sell
37,305
-2,341
-6% -$217K 0.51% 93
2014
Q3
$2.73M Sell
39,646
-43,847
-53% -$3.02M 0.44% 96
2014
Q2
$8.75M Buy
83,493
+5,707
+7% +$598K 1.24% 17
2014
Q1
$6.45M Buy
+77,786
New +$6.45M 0.83% 77